Lupin Diagnostics opens Regional Reference Laboratory in Patna
"By establishing a presence in Patna, the company now looks forward to making a deeper foray into Bihar," the company said.
Patna: Global pharma major Lupin Limited announced today that Lupin Diagnostics has launched its first Regional Reference Laboratory in Patna, Bihar.
The new Regional Reference Laboratory at Patna has capabilities to conduct a broad spectrum of routine and specialized tests in the fields of molecular diagnostics, cytology, microbiology, serology, haematology, immunology and routine biochemistry.
"By establishing a presence in Patna, the company now looks forward to making a deeper foray into Bihar," the company said.
Earlier this year, Lupin Diagnostics opened its Regional Reference Laboratories in Assam and West Bengal.
"Through upcoming launches of laboratories in Jharkhand (Ranchi) and Orissa (Bhubaneshwar), the company is poised to solidify its position in East India. Lupin Diagnostics now operates through more than 100 diagnostic centers in East India and close to 280 centers across the country," the company added.
Ravindra Kumar, Vice President and Head - Lupin Diagnostics said, "We are pleased to announce the launch of our Regional Reference Laboratory in Patna. Through this we plan to provide quality and affordable testing services for a broad range of routine and specialized tests across the state of Bihar. By leveraging our extensive network of LupiMitra centers, we will make quality diagnostics services available to patients even in the most remote areas."
Read also: Lupin, Yabao Pharma collaborate to meet growing demand for pediatric formulations in China
Lupin Diagnostics is a part of Lupin Healthcare Limited, which is a wholly owned subsidiary of Lupin Limited. Founded in October 2021, the company is headquartered in Mumbai, India and provides comprehensive range of diagnostic services to doctors, patients, and consumers. Some of its key consumer-centric features are GPS-enabled temperature–controlled sample movement, smart reports, free home collection, NABL accreditation of each laboratory, trend report analysis, and live home collection booking and tracking.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.